10 Buy-Rated Stocks with Latest Insider Purchases
In this article, we will take a detailed look at the 10 Buy-Rated Stocks with Latest Insider Purchases. For a quick overview of such stocks, read our article 5 Buy-Rated Stocks with Latest Insider...
Annexon Inc. (ANNX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 7,000,000 | $31,780,000 | 0.79% | |
| 2. | Redmile Group Jeremy Green | 5,503,190 | $24,984,483 | +58% | 0.89% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 4,999,975 | $22,699,887 | +113% | 0.04% |
| 4. | Logos Capital Arsani William | 4,950,000 | $22,473,000 | -7% | 2.09% |
| 5. | GMT Capital Thomas E. Claugus | 3,020,474 | $13,712,952 | +8% | 0.51% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.68 | 3,200 | 6,400 | 2024-05-01 | Filing | ||
| $6.07 | 3,200 | 3,200 | 2024-04-08 | Filing | ||
| $2.88 | 350,000 | Large Shareholder, Director | 7,406,024 | 2023-12-26 | Filing | |
| $2.13 | 300,000 | Large Shareholder | 5,701,926 | 2023-05-25 | Filing | |
| $6.80 | 2,647,058 | Large Shareholder, Director | 7,056,024 | 2023-02-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.53 | 2,593 | 82,058 | 2024-02-20 | Filing | ||
| $5.51 | 2,604 | 72,471 | 2024-02-20 | Filing | ||
| $5.48 | 1,951 | 85,641 | 2024-02-20 | Filing | ||
| $5.53 | 1,349 | 48,592 | 2024-02-12 | Filing | ||
| $5.54 | 5,782 | 196,121 | 2024-02-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,685,401 | $43,971,721 | 0% | |
| 2. | 8,061,719 | $36,600,204 | 3.5% | |
| 3. | 7,406,024 | $33,623,349 | 44.74% | |
| 4. | 3,318,579 | $15,066,348 | 0% | |
| 5. | 1,908,326 | $8,663,800 | 0% |
News See All
5 Best Biotech Penny Stocks to Buy Now
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ranks 5th in our list of the best biotech penny stocks to buy now according to hedge funds. Ginkgo Bioworks Holdings, Inc.
Hedge Fund and Insider Trading News: Bill Ackman, Richard Mashaal, Cheyne Capital Management, Three Arrows Capital, Man Group, Annexon Inc (ANNX), Rocket Companies, Inc. (RKT), and More
Billionaire investor William Ackman, who had raised $4 billion in the biggest-ever special purpose acquisition company (SPAC), told investors he would be returning the sum after failing to find a suitable...
Hedge Fund and Insider Trading News: Toscafund Management, Oaktree Capital Management, Worm Capital, BlackRock, Inc. (BLK), and More
MADRID (Reuters) - Fund manager Reade Griffith bought a minority stake in Spanish broadcaster Mediaset Espana after its parent company MediaForEurope launched a public takeover offer, a filing to the ...
10 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green's Redmile Group
In this article, we discuss the 10 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Annexon, Inc. (ANNX): Hedge Fund Sentiment Unchanged
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious...
Is ANNX A Good Stock To Buy Now?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
Billionaire Hedge Funds
